President Donald Trump has issued an executive order to facilitate research into psychedelic drugs for treating PTSD and other mental health problems. This decision has gained significant support from many Americans, particularly military veterans. Two notable advocates, former Energy Secretary Rick Perry and retired Navy SEAL Marcus Luttrell, have voiced their support for these treatments.
FDA Commissioner Dr. Marty Makary has discussed the potential of these therapies in providing breakthroughs for mental health treatment.
Former Netflix Executive’s Legal Battle
Kevin Baillie, previously a top executive for Netflix, is in the news due to a lawsuit he has filed against the company. The New York Post reported that Baillie claims he was terminated in April from Netflix’s Eyeline Studios for disclosing a ketamine treatment for depression during a workplace retreat. This treatment was medically supervised and used to address his clinical depression following the death of his mother in 2022.
The lawsuit indicates that Baillie was earning about $1.1 million annually and contends that Netflix denied him potential severance pay due to remarks he made in January at an off-site retreat. There, he shared his experience with ketamine therapy, prescribed and monitored by medical professionals.
The choice to disclose this personal treatment occurred during a trust-building exercise that encouraged sharing personal experiences. However, Baillie alleges that Netflix’s investigator misconstrued his therapy as recreational drug use during a March 18 inquiry.
The investigation also delved into claims about Baillie’s use of profanity and alcohol, though his previous job reviews had acknowledged his language without requiring him to cease swearing entirely.
Cultural Memo and Company Practices
Netflix’s cultural memo promotes openness and honesty. It emphasizes the ‘keeper test’ to determine if an employee should be retained, which involves assessing their ongoing contribution and potential for retention. The company’s expectations include candid feedback and learning from mistakes.
During the Netflix retreat, Baillie also recounted a story involving Guinness and a headstand trick. When prompted by a colleague, Baillie performed the demonstration, consistent with the expected openness of the session.
Baillie’s lawsuit seeks a jury trial, along with claims for lost wages, compensatory and punitive damages, and damages for emotional distress. Prior to this, Baillie had worked on major film franchises such as ‘Pirates of the Caribbean’ and ‘Harry Potter.’
As of Monday, Netflix had not publicly responded to the allegations. Efforts to contact both Baillie and Netflix for comments by Fox News Digital were not immediately successful.
Ketamine, a Schedule III controlled substance, is federally approved as an anesthetic and also used off-label for treating depression. The FDA separately approved Spravato, a ketamine-derived nasal spray, for treatment-resistant depression under medical supervision.